Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven
Friday, April 3, 2009 - 08:35
in Health & Medicine
It has so far not been proven that long-acting insulin analogues (LAIAs) have an advantage over conventional human insulin in the treatment of patients with type 2 diabetes. Even though the results of a 5-year study are available for one of the two LAIAs assessed (insulin glargine), the potential long-term benefits and harms of this drug class have still not been sufficiently investigated.